Use of Clostridium perfringens Enterotoxin and the Enterotoxin Receptor-Binding Domain (C-CPE) for Cancer Treatment: Opportunities and Challenges
Clostridium perfringens enterotoxin (CPE) causes the symptoms associated with several common gastrointestinal diseases. CPE is a 35 kDa polypeptide consisting of three structured domains, that is, C-terminal domain I (responsible for receptor binding), domain II (responsible for oligomerization and...
Main Authors: | Zhijian Gao, Bruce A. McClane |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Journal of Toxicology |
Online Access: | http://dx.doi.org/10.1155/2012/981626 |
Similar Items
-
Clostridium Perfringens Enterotoxin (CPE) and CPE-Binding Domain (c-CPE) for the Detection and Treatment of Gynecologic Cancers
by: Jonathan D. Black, et al.
Published: (2015-04-01) -
Clostridium perfringens Enterotoxin: Action, Genetics, and Translational Applications
by: John C. Freedman, et al.
Published: (2016-03-01) -
Bystander Host Cell Killing Effects of Clostridium perfringens Enterotoxin
by: Archana Shrestha, et al.
Published: (2016-12-01) -
NanH Is Produced by Sporulating Cultures of Clostridium perfringens Type F Food Poisoning Strains and Enhances the Cytotoxicity of C. perfringens Enterotoxin
by: Jihong Li, et al.
Published: (2021-04-01) -
RIP1, RIP3, and MLKL Contribute to Cell Death Caused by Clostridium perfringens Enterotoxin
by: Archana Shrestha, et al.
Published: (2019-12-01)